We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
-15.5%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$330M
AUM Growth
-$25.2M
(-7.1%)
Cap. Flow
+$49.3M
Cap. Flow
% of AUM
14.94%
Top 10 Holdings %
Top 10 Hldgs %
65.35%
Holding
65
New
13
Increased
15
Reduced
7
Closed
11
Top Buys
| 1 |
Merck
MRK
|
+$25.3M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$23.8M |
| 3 |
Globus Medical
GMED
|
+$17.1M |
| 4 |
Embecta
EMBC
|
+$10.9M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$9.49M |
Top Sells
| 1 |
Cigna
CI
|
+$27.1M |
| 2 |
Sanofi
SNY
|
+$18.7M |
| 3 |
Viatris
VTRS
|
+$9.09M |
| 4 |
Organon & Co
OGN
|
+$9.05M |
| 5 |
Labcorp
LH
|
+$7.14M |
Sector Composition
| 1 | Healthcare | 90.32% |
| 2 | Industrials | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Icon
ICLR
$13B
| $35.6M | 10.77% |
203,311
+7,811
| +4% | +$1.51M |
|
2
Maximus
MMS
$3.03B
| $31.9M | 9.67% |
468,352
+86,929
| +23% | +$6.19M |
|
|
3
Merck
MRK
$298B
| $24.3M | 7.36% |
+270,596
| New | +$25.3M |
|
4
Zimmer Biomet
ZBH
$17.6B
| $21.2M | 6.43% |
187,685
+12,874
| +7% | +$1.38M |
|
|
5
Neurocrine Biosciences
NBIX
$17.3B
| $20.7M | 6.28% |
+187,573
| New | +$23.8M |
|
|
6
Labcorp
LH
$22.6B
| $19.5M | 5.91% |
83,873
-29,420
| -26% | -$7.14M |
|
|
DRUG
7
Bright Minds Biosciences
DRUG
$726M
| $18.3M | 5.54% |
507,562
+55,769
| +12% | +$2.04M |
|
|
8
Globus Medical
GMED
$10.3B
| $15.2M | 4.59% |
+207,000
| New | +$17.1M |
|
9
Teleflex
TFX
$5.76B
| $14.9M | 4.51% |
107,780
+41,008
| +61% | +$6.64M |
|
|
10
Embecta
EMBC
$184M
| $14.1M | 4.28% |
1,107,613
+682,039
| +160% | +$10.9M |
|
|
11
BioMarin Pharmaceuticals
BMRN
$11.3B
| $9.98M | 3.02% |
+141,134
| New | +$9.49M |
|
|
AVR
12
Anteris Technologies
AVR
$871M
| $8.63M | 2.61% |
2,369,960
-40
| -0% | -$257 |
|
13
Haemonetics
HAE
$3.38B
| $8.51M | 2.58% |
+133,966
| New | +$9.11M |
|
14
Annexon
ANNX
$909M
| $6.56M | 1.99% |
3,397,786
+1,030,779
| +44% | +$3.43M |
|
15
Protara Therapeutics
TARA
$230M
| $6.45M | 1.95% |
1,514,300
+76,800
| +5% | +$343K |
|
16
ANI Pharmaceuticals
ANIP
$1.83B
| $5.84M | 1.77% |
87,298
-72,753
| -45% | -$4.35M |
|
|
SEPN
17
Septerna Inc
SEPN
$1.56B
| $4.57M | 1.38% |
788,670
+516,983
| +190% | +$5.9M |
|
18
Praxis Precision Medicines
PRAX
$9.14B
| $4.26M | 1.29% |
+112,500
| New | +$7.03M |
|
19
Avanos Medical
AVNS
$1.17B
| $4.1M | 1.24% |
+285,989
| New | +$4.47M |
|
20
PMV Pharmaceuticals
PMVP
$75.7M
| $4.07M | 1.23% |
3,735,396
+163,229
| +5% | +$222K |
|
21
Tyra Biosciences
TYRA
$1.96B
| $3.87M | 1.17% |
416,617
+175,747
| +73% | +$2.27M |
|
22
Disc Medicine
IRON
$2.87B
| $3.65M | 1.11% |
73,511
| – | – |
|
|
ETNB
23
DELISTED
89bio
ETNB
| $3.63M | 1.1% |
+500,000
| New | +$4.37M |
|
|
AKRO
24
DELISTED
Akero Therapeutics
AKRO
| $3.44M | 1.04% |
+85,000
| New | +$3.6M |
|
25
Vir Biotechnology
VIR
$1.6B
| $3.07M | 0.93% |
473,607
-581,044
| -55% | -$5.17M |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA